article thumbnail

Characterisation of the octogenarians presenting to the diagnostic heart failure clinic: SHEAF registry

Open Heart

We aimed to determine the clinical characteristics which were associated with optimisation of HF pharmacological intervention in the clinic, conducting multivariate regression analysis. were on a beta blocker and on an ACE inhibitor/angiotensin receptor blocker/angiotensin receptor-neprilysin inhibitor, respectively.

article thumbnail

Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials

Open Heart

Background Currently, there is no head-to-head comparison of novel pharmacological treatments for heart failure with reduced ejection fraction (HFrEF). Methods Randomised controlled trials (RCTs) were identified from Medline, Scopus up to June 2021.

article thumbnail

The Management of Chronic Disease

Dr. Sanjay Gupta

Pharmacological treatments: These can be divided into 2 groups Medications that improve quality of life (usually by relieving symptoms) and medications that can prolong life. The next step is to talk about treatments. I break them into 4 categories. Tablets, procedures, rehabilitative therapy and psychological therapies.